Table 3.
Group | Test statistics quantity | P | |||
---|---|---|---|---|---|
| |||||
Living group n (%) | Death group n (%) | ||||
Thyroid function normal or not | Normal | 15 (50) | 2 (7) | χ2=13.87 | 0.000 |
Abnormal | 15 (50) | 28 (93) | |||
Number of affected lung lobe in chest | <3 | 15 (50) | 12 (40) | χ2=0.60 | 0.436 |
>3 | 15 (50) | 18 (60) | |||
Hydrothorax degree | No | 22 (73) | 13 (43) | χ2=5.78 | 0.055 |
A little | 6 (20) | 11 (37) | |||
Hydrops | 2 (7) | 6 (20) | |||
Unilateral and bilateral hydrothorax | No | 22 (73) | 13 (43) | χ2=5.57 | 0.062 |
Unilatera | 4 (13) | 8 (27) | |||
Bilateral | 4 (13) | 9 (30) | |||
Liver function | Normal | 25 (83) | 14 (47) | χ2=8.86 | 0.003 |
Abnormal | 5 (17) | 16 (53) | |||
Alimentary tract hemorrhage | No | 28 (93) | 22 (73) | χ2=4.32 | 0.038 |
Yes | 2 (7) | 8 (27) | |||
State of consciousness | Unconsciousness | 9(30) | 29 (97) | χ2=28.70 | 0.000 |
Clear consciousness | 21 (70) | 1 (3) | |||
Suction right or wrong | No | 15 (50) | 2 (7) | χ2=13.87 | 0.000 |
Yes | 15 (50) | 28 (93) | |||
Nasal feeding diet | No | 30 (100) | 13 (43) | χ2=23.72 | 0.000 |
Yes | 0 (0) | 17 (57) | |||
Bucking | No | 26 (87) | 21 (70) | χ2=2.45 | 0.117 |
Yes | 4 (13) | 9 (30) | |||
Dysphagia | No | 30 (00) | 23 (77) | χ2=7.92 | 0.005 |
Yes | 0 (0) | 7 (23) | |||
Gastrointestinal decompression | No | 30 (100) | 29 (97) | χ2=1.16 | 0.313 |
Yes | 0 (0) | 1 (3) | |||
Fasting | No | 30 (100) | 29 (97) | χ2=1.16 | 0.313 |
Yes | 0 (0) | 1 (3) | |||
After fracture operation | No | 30 (100) | 29 (97) | χ2=1.16 | 0.313 |
Yes | 0 (0) | 1 (3) | |||
Long-term bed | No | 12 (40) | 1 (3) | χ2=11.88 | 0.001 |
Yes | 18 (60) | 29 (97) | |||
Application of antimicrobial agents for the first time after admission | Inappropriate | 3 (10) | 15 (50) | χ2=11.42 | 0.001 |
Appropriate | 27 (90) | 15 (50) | |||
Invasive ventilation | No | 2 (22) | 5 (21) | χ2=0.75 | 0.931 |
Yes | 7 (78) | 19 (79) | |||
Mechanical ventilation | No | 21 (70) | 4 (13) | χ2=19.81 | 0.000 |
Yes | 9 (30) | 26 (87) | |||
Application of hormone | No | 17 (57) | 10 (33) | χ2=3.29 | 0.069 |
Yes | 13 (43) | 20 (67) | |||
Invasive procedure | No | 15 (50) | 3 (10) | χ2=11.42 | 0.001 |
Yes | 15 (50) | 27 (90) | |||
Trachea cannula | No | 24 (80) | 13 (43) | χ2=8.53 | 0.003 |
Yes | 6 (20) | 17 (57) | |||
Stomach tube | No | 15 (50) | 4 (13) | χ2=9.31 | 0.002 |
Yes | 15 (50) | 26 (87) | |||
Catheter | No | 22 (73) | 15 (50) | χ2=3.45 | 0.063 |
Yes | 8 (27) | 15 (50) | |||
Deep vein catheterization | No | 24 (80) | 13 (43) | χ2=8.53 | 0.003 |
Yes | 6 (20) | 17 (57) | |||
ACEI | Nonuse | 17 (57) | 26 (87) | χ2=6.64 | 0.010 |
Use | 13 (43) | 4 (13) | |||
Thymosin | Nonuse | 9 (30) | 20 (67) | χ2=8.75 | 0.004 |
use | 21 (70) | 10 (33) | |||
Thymosin | <4 weeks | 11 (52) | 1 (10) | χ2=5.12 | 0.024 |
>4 weeks | 10 (48) | 9 (90) |